Delivery Order SPE2DB22D2211-SPE2DB24FRHHS
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$84K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,697.97 firm-fixed-price contract is for the delivery of 180-count packages of the generic medication meloxicam 15 mg tablets. There is no set-aside designation for this award. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,867,341 units of Meloxicam 15 mg tablets in 180-count bottles, with a ceiling value of $28,109.04. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 6, 2024. This contract is not designated as a set-aside....
This is a $1,223.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 15 mg tablet units, a medication commonly used to treat pain and inflammation. The contract has a period of performance through June 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 180 tablets of the pharmaceutical product Meloxicam 15 mg, with a ceiling value of $7,503.80. The contract is a firm-fixed price type and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there are no subcontractors indicated. The contract has an ultimate completion date of...
This federal contract award is for the delivery of Meloxicam 15 mg tablets in 180-count bottles. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,774.69, and has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) is a firm fixed price delivery order for MELOXICAM 7.5 MG TABLET 180S valued at $5,066.40. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
This is a $15,918.38 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide a variety of pharmaceutical and medical products. The contract is not set aside and has an ultimate completion date of June 6, 2025. AmerisourceBergen holds a large $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $15,391.80 firm-fixed-price contract is for the provision of pharmaceutical products and medical supplies, with a completion date of September 17, 2024. This award is not set aside for any specific business type. Amerisourcebergen is a major supplier of pharmaceuticals and medical commodities to the U.S. federal government, supporting...
This $4,445.64 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment, to support military treatment facilities and other federal healthcare providers. The contract has an ultimate completion date of August 8,...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $25,129.86 firm fixed-price contract is for the supply of pharmaceutical and medical products, with a period of performance through May 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has several indefinite delivery contracts (IDCs) with the DLA and Department of Justice to provide a...